SERTIFIKAT 30 Juli - Clinical Advance in Injectable Therapy For Management of T2DM Fixed Ratio Combination Basal Insulin-Glp1 Receptor Agonist
SERTIFIKAT 30 Juli - Clinical Advance in Injectable Therapy For Management of T2DM Fixed Ratio Combination Basal Insulin-Glp1 Receptor Agonist
Diberikan Kepada
PESERTA
KEGIATAN ILMIAH ONLINE : “Clinical Advance In Injectable Therapy for Management of
T2DM: Fixed Ratio Combination Basal insulin-Glp1 Receptor Agonist”
Kegiatan diselenggrakan oleh PAPDI Cabang Makassar, PERKENI Cabang Makassar, & Departemen Ilmu Penyakit Dalam FK UNHAS